Prelude Therapeutics (PRLD)
NASDAQ: PRLD
· Real-Time Price · USD
0.84
-0.10 (-11.11%)
At close: Aug 15, 2025, 3:59 PM
0.87
4.05%
After-hours: Aug 15, 2025, 04:54 PM EDT
Prelude Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 40.27M | 12.47M | 11.13M | 27.83M | 24.71M | 25.29M | 15.9M | 26.45M | 18.2M | 30.61M | 52.02M | 50.71M | 51.63M | 31.83M | 61.42M | 343.12M | 362.99M |
Short-Term Investments | 58.8M | 121.14M | 142.49M | 152.02M | 177.22M | 207.64M | 214.61M | 228.54M | 154.05M | 171.12M | 172.02M | 195.6M | 214.56M | 259.4M | 259.44M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 4.04M | 4.04M | 4.04M | 4.04M | 4.04M | 17.07M | 4.04M | 4.04M | 4.04M | 4.04M | 259.4M | n/a | n/a | n/a |
Other Long-Term Assets | 4.15M | 4.15M | 4.45M | 405K | 295K | 295K | 12.47M | 9.36M | -743K | 5.38M | 4.93M | 309K | 309K | -255.06M | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.33M | 2.28M | 2.76M | 2.87M | 3.44M | 2.65M | 4.41M | 5.22M | 3.01M | 2.65M | 2.85M | 2.32M | n/a | n/a | 5.03M | 1.46M | 2.03M |
Total Current Assets | 102.4M | 135.9M | 156.39M | 182.71M | 205.37M | 235.59M | 234.92M | 260.21M | 175.26M | 204.38M | 226.89M | 248.62M | 269.97M | 295.12M | 325.9M | 344.57M | 365.02M |
Property-Plant & Equipment | 34.7M | 35.47M | 36.38M | 37.13M | 37.4M | 37.74M | 7.08M | 7M | 6.73M | 6.7M | 6.46M | 6.08M | 6.35M | 5.64M | 5.32M | 5.01M | 4.81M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 38.86M | 39.62M | 40.83M | 41.58M | 41.74M | 42.08M | 23.59M | 20.4M | 23.06M | 16.12M | 15.43M | 10.43M | 10.7M | 9.98M | 5.32M | 5.01M | 4.81M |
Total Assets | 141.26M | 175.51M | 197.22M | 224.29M | 247.11M | 277.67M | 258.51M | 280.61M | 198.32M | 220.5M | 242.33M | 259.06M | 280.67M | 305.1M | 331.22M | 349.58M | 369.83M |
Account Payables | 5.83M | 7.73M | 5.92M | 6.17M | 5.31M | 4.58M | 5.17M | 5.58M | 7.08M | 6.78M | 10.25M | 6.27M | 7.39M | 7.84M | 11.06M | 6.84M | 4.84M |
Deferred Revenue | n/a | n/a | n/a | 3M | -5.31M | 14.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 2.74M | n/a | 1.48M | 475K | 938K | 1.39M | 1.83M | 1.39M | 1.82M | 1.86M | 1.74M | 1.84M | 1.4M | 1.4M |
Other Current Liabilities | 4.55M | 9.79M | 8.39M | 3.35M | 800K | 5.13M | 7.33M | 4.11M | 6.69M | 5.58M | 4.35M | 2.21M | 1.94M | 3.27M | 1.67M | 2.7M | 1.84M |
Total Current Liabilities | 19.79M | 25.64M | 22.22M | 23.34M | 17.64M | 21.83M | 16.89M | 15.19M | 19.66M | 21.7M | 21.56M | 15.81M | 16.07M | 19.2M | 19.66M | 14.68M | 12.42M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 3.03M | 3.09M | 3.15M | 3.21M | 3.28M | 3.34M | 3.36M | 3.36M | 3.36M | 3.36M | 3.36M | 2.4M | 2.4M | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 18.3M | 18.41M | 18.57M | 18.68M | 18.73M | 18.75M | 3.36M | 3.36M | 3.36M | 3.36M | 3.36M | 2.4M | 2.79M | 9.58M | 312K | 543K | 840K |
Total Liabilities | 38.08M | 44.06M | 40.79M | 42.02M | 36.37M | 40.58M | 20.25M | 18.55M | 23.02M | 25.06M | 24.92M | 18.21M | 18.86M | 19.2M | 19.98M | 15.22M | 13.26M |
Total Debt | 17.92M | 18.02M | 18.14M | 18.2M | 17.64M | 16.89M | 475K | 938K | 1.39M | 1.83M | 1.39M | 1.82M | 2.25M | 1.74M | 2.15M | 1.95M | 2.24M |
Common Stock | 5K | 5K | 4K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K |
Retained Earnings | -615.65M | -583.56M | -554.83M | -522.56M | -487.82M | -456.39M | -423.31M | -392.71M | -362.28M | -334.56M | -305.92M | -275.96M | -248.59M | -219.12M | -186.28M | -155.59M | -128.73M |
Comprehensive Income | 12K | 35K | 167K | -290K | -235K | 223K | -605K | -711K | -398K | -1.69M | -2.36M | -2.29M | -2.31M | -711K | -176K | n/a | n/a |
Shareholders Equity | 103.18M | 131.46M | 156.43M | 182.28M | 210.73M | 237.09M | 238.26M | 262.06M | 175.3M | 195.44M | 217.41M | 240.84M | 261.81M | 285.9M | 311.24M | 334.36M | 356.57M |
Total Investments | 58.8M | 121.14M | 142.49M | 156.06M | 181.26M | 207.64M | 214.61M | 228.54M | 171.12M | 171.12M | 172.02M | 195.6M | 214.56M | 259.4M | 259.44M | n/a | n/a |